World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
58
Citations
10393
World Ranking
3475
National Ranking
1372

Overview

Paul M. Sondel is affiliated with the University of Wisconsin-Madison in the United States. Their research spans multiple disciplines with a focus on medicine, biochemistry, genetics and molecular biology, and immunology and microbiology. The main subfields of their work include oncology, immunology, neurology, molecular biology, and radiology, nuclear medicine and imaging.

The scientist's research covers a range of topics that emphasize neuroblastoma research and treatments, immunotherapy and immune responses, cancer immunotherapy and biomarkers, CAR-T cell therapy research, cancer related to hypoxia and metabolism, monoclonal and polyclonal antibodies research, and broader cancer research and treatments.

Some of the recent publications by Paul M. Sondel include:

  • Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade (2021), published in Science Translational Medicine
  • Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032 (2021), published in Clinical Cancer Research
  • Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group (2020), published in Journal of Clinical Oncology
  • Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment (2022), published in Nature Communications
  • Immunotherapy of Neuroblastoma: Facts and Hopes (2022), published in Clinical Cancer Research

Frequent co-authors include:

  • Amy K. Erbe
  • Alexander L. Rakhmilevich
  • Zachary S. Morris
  • Arika S. Feils
  • Anna Hoefges

The main publication venues for this researcher include:

  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer
  • Cancer Research
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells

    Paul Fisch;Miroslav Malkovsky;Susan Kovats;Els Sturm

  • Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens

    Robert DeMars;Robert DeMars;Cecile C Chang;Cecile C Chang;Stephen Shaw;Stephen Shaw;Pamela J Reitnauer;Pamela J Reitnauer

  • Phase I Study of Chimeric Human/Murine Anti–Ganglioside GD2 Monoclonal Antibody (ch14.18) With Granulocyte-Macrophage Colony-Stimulating Factor in Children With Neuroblastoma Immediately After Hematopoietic Stem-Cell Transplantation: A Children’s Cancer Group Study

    M. Fevzi Ozkaynak;Paul M. Sondel;Mark D. Krailo;Jacek Gan

  • Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes.

    Joseph M. Carlin;Ernest C. Borden;Paul M. Sondel;Gerald I. Byrne

  • Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.

    R. R. Brown;Y. Ozaki;S. P. Datta;Ernest C Borden

  • A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children’s Oncology Group

    Kaci L. Osenga;Jacquelyn A. Hank;Mark R. Albertini;Jacek Gan

  • Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

    David M. King;Mark R. Albertini;Heidi Schalch;Jacquelyn A. Hank

  • Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

    Ravi B. Patel;Reinier Hernandez;Peter Carlson;Joseph Grudzinski

  • Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.

    Alice L. Yu;Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Arlene Naranjo

  • Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

    David C. Delgado;Jacquelyn A. Hank;Jill Kolesar;David Lorentzen

  • Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity.

    Jeff A. Sosman;Peter C. Kohler;Jacquelyn Hank;Karen H. Moore

  • A multigene family on human chromosome 12 encodes natural killer-cell lectins.

    Toshio Yabe;Cynthia McSherry;Fritz H. Bach;Paul Fisch

  • Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.

    Rajen Mody;Alice L Yu;Alice L Yu;Arlene Naranjo;Fan F Zhang

  • Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells.

    Joel G. Turner;Alexander L. Rakhmilevich;Lyudmila Burdelya;Zane Neal

  • Lymphokines and cytokines as cancer treatment. Immunotherapy realized.

    Ernest C. Borden;Paul M. Sondel

  • Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells.

    P M Sondel;J A Hank;P C Kohler;B P Chen

  • Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).

    Jacquelyn A. Hank;Jean E. Surfus;Jacek Gan;Peter Jaeger

  • CD40 Ligation Activates Murine Macrophages via an IFN-γ-Dependent Mechanism Resulting in Tumor Cell Destruction In Vitro

    Ilia N. Buhtoiarov;Hillary Lum;Gideon Berke;Donna M. Paulnock

  • Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cells.

    E. Sturm;E. Braakman;P. Fisch;R. J. Vreugdenhil

  • Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model.

    Jose M. Ayuso;Jose M. Ayuso;Regan Truttschel;Max M. Gong;Mouhita Humayun

  • Antigenic requirements for triggering of cytotoxic T lymphocytes.

    Fritz H. Bach;Catherine Grillot-Courvalin;Oded J. Kuperman;Hans W. Sollinger

Frequent Co-Authors

Jacquelyn A. Hank
Jacquelyn A. Hank University of Wisconsin–Madison
Stephen D. Gillies
Stephen D. Gillies MSD (United States)
Jeffrey A. Sosman
Jeffrey A. Sosman Northwestern University
Ralph A. Reisfeld
Ralph A. Reisfeld Scripps Research Institute
Alice L. Yu
Alice L. Yu University of California, San Diego
Wendy B. London
Wendy B. London Harvard University
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Robert DeMars
Robert DeMars University of Wisconsin–Madison
Joan H. Schiller
Joan H. Schiller University of Virginia
Paul M. Harari
Paul M. Harari University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to microbiology opens up diverse career pathways. For instance, pursuing healthcare-focused programs can lead to roles like a child life specialist, a profession where understanding biology and human development is crucial. Interested students often research how much do child life specialists make to gauge financial prospects in the field.

For those with unique backgrounds, including individuals with previous convictions, it's encouraging to note the availability of options like the best degrees for felons. Many online programs provide pathways to careers in healthcare and science that are accessible and lead to rewarding opportunities.

Another promising direction is becoming a functional medicine NP, which combines traditional microbiology knowledge with patient-centered care. This role is growing in demand as holistic health approaches become more mainstream.

For those drawn to the administrative or coding side of healthcare, obtaining a CPC certification can be a smart move. Understanding the cpc certification salary and career paths helps prospective students evaluate the benefits of this certification, especially when paired with a science background.

Choosing the right online degree linked to microbiology can open multiple doors in the healthcare and science sectors, each with unique benefits and career growth potential.

Best Scientists Citing Paul M. Sondel

Trending Scientists

Recently Published Articles